Semaglutide is a versatile medication that offers benefits for people with type 2 diabetes and those seeking to lose weight
Most of us have probably heard about type 2 diabetes, a condition where the body cant maintain healthy blood sugar levels
Clinical trials have shown substantial weight reduction, with participants on the highest dose losing almost 21% of their body weight
In Nederland staat Mounjaro (tirzepatide) al een ruim een jaar als medicijn tegen zowel type-2-diabetes als obesitas geregistreerd, maar het zal straks alleen voor diabetespatinten vergoed gaan worden door de zorgverzekeraars
Remember, if any of these things happen, it is very important to speak with a grown-up and call your doctor
While we understand that off-label prescribing can be beneficial in some circumstances, we cannot support it when it is directly contributing to ongoing shortages for those people living with type 2 diabetes and the impact this has on managing it well